These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 19836875
21. Gonadotropin releasing hormone analogue antiandrogen failure secondary to a pituitary adenoma. Ogan K, Berger M, Ball R. J Urol; 1998 Aug; 160(2):497-8. PubMed ID: 9679910 [No Abstract] [Full Text] [Related]
22. Three simultaneous paraneoplastic manifestations (ichthyosis acquisita, Bazex syndrome, and Leser-Trélat sign) with prostate adenocarcinoma. da Rosa AC, Pinto GM, Bortoluzzi JS, Duquia RP, de Almeida HL. J Am Acad Dermatol; 2009 Sep; 61(3):538-40. PubMed ID: 19700026 [No Abstract] [Full Text] [Related]
23. Paraneoplastic leukocytoclastic vasculitis in chronic lymphoid leukemia. Yadav BS, Sharma SC, Kapoor RK. J Cancer Res Ther; 2006 Sep; 2(4):206-8. PubMed ID: 17998707 [Abstract] [Full Text] [Related]
24. Syndrome of inappropriate antidiuretic hormone secretion: a rare complication of prostate cancer. Garzotto M, Beer TM. J Urol; 2001 Oct; 166(4):1386. PubMed ID: 11547083 [No Abstract] [Full Text] [Related]
25. [Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate]. Berenguer Sánchez A. Arch Esp Urol; 2002 Sep; 55(7):771-5. PubMed ID: 12380304 [No Abstract] [Full Text] [Related]
27. [A case of dermatomyositis associated with prostatic carcinoma: a case report]. Sekine Y, Kubota Y, Kurihara J. Hinyokika Kiyo; 2004 Feb; 50(2):95-7. PubMed ID: 15101164 [Abstract] [Full Text] [Related]
28. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss. Preston DM, Torréns JI, Harding P, Howard RS, Duncan WE, McLeod DG. Prostate Cancer Prostatic Dis; 2002 Feb; 5(4):304-10. PubMed ID: 12627216 [Abstract] [Full Text] [Related]
29. Paraneoplastic subacute sensory neuronopathy in association with adenocarcinoma of the prostate. Cowley A, Pascoe S. BMJ Case Rep; 2011 Jul 28; 2011():. PubMed ID: 22689835 [Abstract] [Full Text] [Related]
30. Neoadjuvant doxil chemotherapy prior to androgen ablation plus radiotherapy for high-risk localized prostate cancer: feasibility and toxicity. Oh WK, Kaplan ID, Febbo P, Prisby J, Manola J, Kaufman DS, Kantoff PW. Am J Clin Oncol; 2003 Jun 28; 26(3):312-6. PubMed ID: 12796607 [Abstract] [Full Text] [Related]
31. Bilaterally mammary acanthosis nigricans as paraneoplastic manifestation of prostate adenocarcinoma. Tammaro A, Giulianelli V, Parisella F, Persechino S. G Ital Dermatol Venereol; 2016 Oct 28; 151(5):578-9. PubMed ID: 27595210 [No Abstract] [Full Text] [Related]